Description

A Diabetes Autoantibody Panel is a blood test that detects autoantibodies—proteins produced by the immune system that mistakenly attack the body’s own insulin-producing cells in the pancreas. This panel is primarily used to help diagnose type 1 diabetes, predict the risk of developing it, and distinguish it from other forms of diabetes.

Purpose of the Test:

  • Diagnose Type 1 Diabetes: Confirms autoimmune destruction of pancreatic beta cells.
  • Predict Risk: Identifies individuals at higher risk for developing type 1 diabetes, including children and relatives of patients with type 1 diabetes.
  • Guide Treatment: Helps clinicians determine whether insulin therapy or other management strategies are appropriate.

Typical Autoantibodies Included:

  1. GAD65 (Glutamic Acid Decarboxylase Antibody):
  • Most common autoantibody in type 1 diabetes.
  1. IA-2 (Islet Antigen-2 Antibody):
  • Often found in people with recent-onset type 1 diabetes.
  1. Insulin Autoantibody (IAA):
  • Detects antibodies against insulin, typically in children.
  1. Zinc Transporter 8 Antibody (ZnT8):
  • Helps identify autoimmune activity in the pancreas.

When This Test Is Ordered:

  • If a patient presents with high blood sugar or diabetic symptoms but the type of diabetes is unclear.
  • For children or adults with a family history of type 1 diabetes.
  • To monitor autoimmune activity in patients with a recent diagnosis of type 1 diabetes.

What Abnormal Results Mean:

  • Positive Autoantibodies: Suggest autoimmune destruction of pancreatic beta cells and indicate type 1 diabetes or increased risk.
  • Negative Autoantibodies: More consistent with type 2 diabetes, MODY (maturity-onset diabetes of the young), or other forms of non-autoimmune diabetes.

Preparation:

  • Fasting not required.
  • Blood is drawn via venipuncture.